As a member of the class IIa histone deacetylases (HDACs), HDAC9 catalyzes the deacetylation of histones and transcription factors, commonly leading to the suppression of gene transcription. The activity of HDAC9 is regulated transcriptionally and post-translationally. HDAC9 is known to play an essential role in regulating myocyte and adipocyte differentiation and cardiac muscle development. Also, recent studies have suggested that HDAC9 is involved in the pathogenesis of chronic diseases, including cardiovascular diseases, osteoporosis, autoimmune disease, cancer, obesity, insulin resistance, and liver fibrosis. HDAC9 modulates the expression of genes related to the pathogenesis of chronic diseases by altering chromatin structure in their promotor region or reducing the transcriptional activity of their respective transcription factors. This review summarizes the current knowledge of the regulation of HDAC9 expression and activity. Also, the roles of HDAC9 in the pathogenesis of chronic diseases are discussed, along with potential underlying mechanisms.

Citations

Citations to this article as recorded by  

• Impact of housing temperature on adipose tissue HDAC9 expression and adipogenic differentiation in high fat‐fed mice
  Samah Ahmadieh, Brandee Goo, Abdalrahman Zarzour, David Kim, Hong Shi, Praneet Veerapaneni, Ronnie Chouhaita, Nicole K. H. Yiew, Carla Dominguez Gonzalez, Akash Chakravartty, James Pennoyer, Nazeera Hassan, Tyler W. Benson, Mourad Ogbi, David J. Fulton, R
  Obesity.2024; 32(1): 107.     CrossRef
• HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD
  Guixian Zheng, Chao Li, Xiaoli Chen, Zhaohui Deng, Ting Xie, Zengyu Huo, Xinyan Wei, Yanbing Huang, Xia Zeng, Yu Luo, Jing Bai
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(3): 167023.     CrossRef
• Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes
  Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
  Scientific Reports.2024;[Epub]     CrossRef
• HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
  Totan Das, Samima Khatun, Tarun Jha, Shovanlal Gayen
  Mini-Reviews in Medicinal Chemistry.2024; 24(7): 767.     CrossRef
• Targeting histone deacetylases for cancer therapy: Trends and challenges
  Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
  Acta Pharmaceutica Sinica B.2023; 13(6): 2425.     CrossRef
• Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
  Guokai Zhang, Zhenying Liu, Zihan Li, Bing Zhang, Pengyu Yao, Yun Qiao
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Research Progress on Histone Deacetylase Inhibitors
  玉姜 汤
  Hans Journal of Medicinal Chemistry.2023; 11(02): 116.     CrossRef
• HDAC9 Inhibition as a Novel Treatment for Stroke
  Hugh S. Markus
  Stroke.2023; 54(12): 3182.     CrossRef
• Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
  Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
  Pharmacological Research.2023; 198: 107009.     CrossRef
• Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration
  Ming Lei, Hui Lin, Deyao Shi, Pan Hong, Hui Song, Bomansaan Herman, Zhiwei Liao, Cao Yang
  Cellular & Molecular Biology Letters.2023;[Epub]     CrossRef
• Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
  Sylvia Fong, Bridget Yates, Choong-Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, Adebayo Lawal, Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, K. John Pasi, Wing Yen Wong
  Nature Medicine.2022; 28(4): 789.     CrossRef
• Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
  Michael Hauke, Robert Eckenstaler, Anne Ripperger, Anna Ender, Heike Braun, Ralf A. Benndorf
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
  Long Xu, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, Jing Su
  Biomedicines.2022; 10(2): 374.     CrossRef
• Common protein-coding variants influence the racing phenotype in galloping racehorse breeds
  Haige Han, Beatrice A. McGivney, Lucy Allen, Dongyi Bai, Leanne R. Corduff, Gantulga Davaakhuu, Jargalsaikhan Davaasambuu, Dulguun Dorjgotov, Thomas J. Hall, Andrew J. Hemmings, Amy R. Holtby, Tuyatsetseg Jambal, Badarch Jargalsaikhan, Uyasakh Jargalsaikh
  Communications Biology.2022;[Epub]     CrossRef
• Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
  Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi
  Neurological Sciences.2021; 42(3): 951.     CrossRef
• Emerging roles of SIRT6 in human diseases and its modulators
  Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou
  Medicinal Research Reviews.2021; 41(2): 1089.     CrossRef
• Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
  Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
  Life.2021; 11(2): 90.     CrossRef
• circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis
  Huan Wan, Ting You, Wei Luo
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
  Chun Yang, Stéphane Croteau, Pierre Hardy
  Cellular Oncology.2021; 44(5): 997.     CrossRef
• Dual HDAC/BRD4 inhibitors against cancer
  Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
  Medicinal Chemistry Research.2021; 30(10): 1822.     CrossRef
• miR‐211‐5p is down‐regulated and a prognostic marker in bladder cancer
  Weisheng Wang, Zhiming Liu, Xuegang Zhang, Junning Liu, Junqing Gui, Maorong Cui, Yong Li
  The Journal of Gene Medicine.2020;[Epub]     CrossRef